Literature DB >> 6190187

Increased self-administration of d-amphetamine by rats pretreated with metergoline.

W H Lyness, K E Moore.   

Abstract

Rats trained to self-administer d-amphetamine were pretreated with metergoline, a long-acting 5-hydroxytryptaminergic antagonist, and immediately placed in self-administration cages for 8 hours. During the first 3 hours after metergoline the normal pattern of d-amphetamine self-administration was unaltered, but thereafter the rate of self-injections was increased. Between 4 and 6 hr the self-injections in metergoline-treated rats were increased in a regular fashion and subsequently (7-8 hr) in a stereotyped manner, i.e., rapid bursts of lever presses with little space between injections. In amphetamine-naive rats the levels of striatal and nucleus accumbens dopamine metabolites, dihydroxyphenylacetic acid and homovanillic acid, rose with time after metergoline injection. Levels of 5-hydroxyindoleacetic acid remained unchanged in these brain areas. The neurochemical results suggest a correlation between the dopaminergic actions of metergoline and d-amphetamine self-administration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190187     DOI: 10.1016/0091-3057(83)90013-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  3 in total

Review 1.  In vivo analysis of the role of dopamine in stimulant and opiate self-administration.

Authors:  A Gratton
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

2.  Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine.

Authors:  P J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

3.  Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin.

Authors:  E A Loh; D C Roberts
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.